Brief: Cyclopharm Says Expects 1H FY 2022 Total Unaudited Group Sales Revenue To Be About A$11.3 Mln

Cyclopharm

04/07/2022 02:27

July 4 (Reuters) - Cyclopharm Ltd  CYC.AX :
    * 1H 2022 BUSINESS UPDATE - RECORD REVENUES
    * SEES 1H FY 2022 TOTAL UNAUDITED GROUP SALES REVENUE TO BE
ABOUT
A$11.3 MILLION
    * NET CASH POSITION AT HALF YEAR EXPECTED TO BE A$26 MILLION
    * 1H FY 2022 REVENUES FROM PREDOMINANTLY RECURRING PATIENT
ADMINISTRATION SETS CONSUMABLES EXPECTED TO BE  21% HIGHER THAN
PCP

Source text for Eikon:  ID:nASXc4BGrQ 
Further company coverage:  CYC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))